Insights

Innovative Therapeutics Nuvaira specializes in developing groundbreaking therapies for obstructive lung diseases such as COPD and asthma, offering opportunities to collaborate with healthcare providers seeking advanced treatment options.

Regulatory Progress The company's flagship dNerva Lung Denervation System holds CE Mark approval and is in clinical trials in the US, presenting potential for early adoption and strategic partnerships to expand market reach.

Strong Patent Portfolio With over 75 patents issued or pending worldwide, Nuvaira has a defensible technology base, which can be leveraged to differentiate products and explore licensing or joint ventures.

Funding and Growth Having raised $79 million and achieved revenue between 1 and 10 million, Nuvaira is in a growth phase, offering opportunities for investment, distribution partnerships, and sales expansion.

Leadership and Expertise Strategic hires of industry veterans and board members from established medtech firms indicate a strong leadership team, ideal for forming collaborations focused on clinical development and commercial scaling.

Similar companies to NUVAIRA, Inc.

NUVAIRA, Inc. Tech Stack

NUVAIRA, Inc. uses 8 technology products and services including Font Awesome, Google Fonts API, JSON-LD, and more. Explore NUVAIRA, Inc.'s tech stack below.

  • Font Awesome
    Font Scripts
  • Google Fonts API
    Font Scripts
  • JSON-LD
    Javascript Frameworks
  • Priority Hints
    Performance
  • WP Engine
    Platform As A Service
  • Yoast SEO
    Search Engines
  • reCAPTCHA
    Security
  • Nginx
    Web Servers

Media & News

NUVAIRA, Inc.'s Email Address Formats

NUVAIRA, Inc. uses at least 2 format(s):
NUVAIRA, Inc. Email FormatsExamplePercentage
FLast@holaira.comJDoe@holaira.com
92%
First.Middle@holaira.comJohn.Michael@holaira.com
8%
FLast@nuvaira.comJDoe@nuvaira.com
46%
Last@nuvaira.comDoe@nuvaira.com
4%
FLast@nuvaira.comJDoe@nuvaira.com
46%
Last@nuvaira.comDoe@nuvaira.com
4%

Frequently Asked Questions

Where is NUVAIRA, Inc.'s headquarters located?

Minus sign iconPlus sign icon
NUVAIRA, Inc.'s main headquarters is located at 6500 Wedgewood Road North Maple Grove, Minnesota 55311 United States. The company has employees across 2 continents, including North AmericaEurope.

What is NUVAIRA, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact NUVAIRA, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is NUVAIRA, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
NUVAIRA, Inc.'s official website is nuvaira.com and has social profiles on LinkedIn.

What is NUVAIRA, Inc.'s NAICS code?

Minus sign iconPlus sign icon
NUVAIRA, Inc.'s NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does NUVAIRA, Inc. have currently?

Minus sign iconPlus sign icon
As of March 2026, NUVAIRA, Inc. has approximately 22 employees across 2 continents, including North AmericaEurope. Key team members include Ceo: D. W.Vice President Finance: S. S.Vice President International Development: S. G.. Explore NUVAIRA, Inc.'s employee directory with LeadIQ.

What industry does NUVAIRA, Inc. belong to?

Minus sign iconPlus sign icon
NUVAIRA, Inc. operates in the Medical Equipment Manufacturing industry.

What technology does NUVAIRA, Inc. use?

Minus sign iconPlus sign icon
NUVAIRA, Inc.'s tech stack includes Font AwesomeGoogle Fonts APIJSON-LDPriority HintsWP EngineYoast SEOreCAPTCHANginx.

What is NUVAIRA, Inc.'s email format?

Minus sign iconPlus sign icon
NUVAIRA, Inc.'s email format typically follows the pattern of FLast@holaira.com. Find more NUVAIRA, Inc. email formats with LeadIQ.

How much funding has NUVAIRA, Inc. raised to date?

Minus sign iconPlus sign icon
As of March 2026, NUVAIRA, Inc. has raised $79M in funding. The last funding round occurred on Feb 01, 2019 for $79M.

When was NUVAIRA, Inc. founded?

Minus sign iconPlus sign icon
NUVAIRA, Inc. was founded in 2008.

NUVAIRA, Inc.

Medical Equipment ManufacturingMinnesota, United States11-50 Employees

Nuvaira, Inc. develops innovative and groundbreaking therapies that aim to improve the lives of the more than 65 million people around the world with obstructive lung disease. Founded in 2008, Nuvaira was established to address clinical needs in the treatment of overactive airway nerves, a common disease feature of both COPD and asthma. 

Nuvaira is a privately held medical device company, headquartered in Minneapolis, Minnesota USA and has more than 75 patents issued and pending worldwide.

The dNerva® Lung Denervation System is CE Mark approved.  The dNerva® lung denervation system is under clinical investigation and is not commercially available in the USA.

Section iconCompany Overview

Headquarters
6500 Wedgewood Road North Maple Grove, Minnesota 55311 United States
Phone number
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2008
Employees
11-50

Section iconFunding & Financials

  • $79M

    NUVAIRA, Inc. has raised a total of $79M of funding over 1 rounds. Their latest funding round was raised on Feb 01, 2019 in the amount of $79Mas a equity financing.

  • $1M$10M

    NUVAIRA, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $79M

    NUVAIRA, Inc. has raised a total of $79M of funding over 1 rounds. Their latest funding round was raised on Feb 01, 2019 in the amount of $79Mas a equity financing.

  • $1M$10M

    NUVAIRA, Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.